Biohaven Announces Presentation at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting

/PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) announced today that it will present an oral and poster presentation demonstrating the preclinical efficacy and...

Related Keywords

Michael Bozik ,Steven Dworetzky ,Jennifer Porcelli ,Mike Beyer ,Exchange Commission ,Drug Administration ,American Society For Experimental Neurotherapeutics Annual Meeting ,Ion Channel Research Development ,Prnewswire Biohaven Ltd ,Sam Brown Inc ,Ion Channel Research ,Private Securities Litigation Reform Act ,Financial Condition ,Biohaven Ltd ,